NASDAQ
Minerva Neurosciences, Inc. (NERV) has a free cash flow growth of -121019.82% as of Friday, May 29, 2026. This represents a 501788.38% decrease compared to its 12-month average of -24.11%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.